ANDROGENS, ESTROGENS AND PROGESTERONE IN PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA, RELATION WITH GROWTH AND TRANCRIPTION FACTORS
- Autores: Kovaleva I.V1, Spirina L.V1,2
-
Afiliações:
- Siberian State Medical University
- Cancer Research Institute, Tomsk NMRC of the RAS
- Edição: Volume 15, Nº 3S (2020)
- Páginas: 94-95
- Seção: Articles
- ##submission.dateSubmitted##: 17.01.2023
- ##submission.datePublished##: 15.12.2020
- URL: https://genescells.ru/2313-1829/article/view/122829
- DOI: https://doi.org/10.23868/gc122829
- ID: 122829
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Sobre autores
I. Kovaleva
Siberian State Medical University
Email: irina.kovalyova.kovaleva@mail.ru
Tomsk, Russia
L. Spirina
Siberian State Medical University; Cancer Research Institute, Tomsk NMRC of the RASTomsk, Russia
Bibliografia
- Schatten H. Brief Overview of Prostate Cancer Statistics, Grading, Diagnosis and Treatment Strategies. Adv Exp Med Biol. 2018; 1095:1-14.
- Feng Q., He B. Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer. Front Oncol. 2019; 9: 858.
- Chen R., Yu Y., Dong X. Progesterone receptor in the prostate: A potential suppressor for benign prostate hyperplasia and prostate cancer. J Steroid Biochem Mol Biol. 2017; 166: 91-96. А.А. Коваленко, М.В. Захарова, А.П. Шварц,